<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04218058</url>
  </required_header>
  <id_info>
    <org_study_id>0020</org_study_id>
    <nct_id>NCT04218058</nct_id>
  </id_info>
  <brief_title>Reduction of Zygomatic Arch in Zygomaticomaxillary Fractures</brief_title>
  <official_title>Ultrasound Guided Closed Reduction Versus Open Reduction of Zygomatic Arch in Zygomaticomaxillary Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare between ultrasound guided closed reduction and open reduction of zygomatic arch in
      cases of zygomaticomaxillary fracture.

      To evaluate the role of intra-operative ultrasound during zygomatic arch reduction.

      To compare between esthetic appearance, orbital movement, wound healing, scaring, and
      postoperative ocular complications in both groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2018</start_date>
  <completion_date type="Actual">November 23, 2019</completion_date>
  <primary_completion_date type="Actual">September 25, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>zygomatic arch reduction</measure>
    <time_frame>immediate post operative CT scan</time_frame>
    <description>to measure the amount of zygomatic arch reduction on postoperative ct scan and compare it with the normal side</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Zygomatic Arch Reduction</condition>
  <arm_group>
    <arm_group_label>study (ultrasound guided closed reduction of zygomatic arch))</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>reduction of zygomatic arch guided by ultrasound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control (open reduction of zygomatic arch)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>open reduction of zygomatic arch through coronal incision</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>reduction of zygomatic arch in zygomaticomaxillary complex fracture</intervention_name>
    <description>ultrasound guided reduction of zygomatic arch</description>
    <arm_group_label>control (open reduction of zygomatic arch)</arm_group_label>
    <arm_group_label>study (ultrasound guided closed reduction of zygomatic arch))</arm_group_label>
    <other_name>open reduction of zygomatic arch in zygomaticomaxillary complex fracture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting with ZMC fractures that require reduction and fixation

          -  Patients between 20 to 50 years old with no gender predilections

        Exclusion Criteria:

          -  Existence of infection at the fracture line

          -  Chronic systemic diseases such as metabolic bone disease, immunocompromised status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dentistry</name>
      <address>
        <city>Alexandria</city>
        <zip>21500</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 30, 2019</study_first_submitted>
  <study_first_submitted_qc>January 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2020</study_first_posted>
  <last_update_submitted>January 1, 2020</last_update_submitted>
  <last_update_submitted_qc>January 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Tasneem Ahmed Mabrouk Amer</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

